CHULABHORN HOSPITAL
🇹🇭Thailand
- Country
- 🇹🇭Thailand
- Ownership
- -
- Established
- 2009-01-01
- Employees
- -
- Market Cap
- -
Clinical Trials
17
Active:2
Completed:8
Trial Phases
5 Phases
Phase 1:3
Phase 2:2
Phase 3:5
+2 more phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (17 trials with phase data)• Click on a phase to view related trials
Not Applicable
5 (29.4%)Phase 3
5 (29.4%)Phase 1
3 (17.6%)Phase 2
2 (11.8%)Phase 4
2 (11.8%)Effects of Physiotherapy Via Telerehabilitation in Patients With COVID-19
Not Applicable
Completed
- Conditions
- Long COVID-19Cardiopulmonary FunctionCOVID-19Physical Function
- First Posted Date
- 2024-02-09
- Last Posted Date
- 2024-06-05
- Lead Sponsor
- Chulabhorn Hospital
- Target Recruit Count
- 32
- Registration Number
- NCT06251011
- Locations
- 🇹🇭
Chulabhorn hospital, Lak Si, Bangkok, Thailand
Prevention of Mucositis in Patients With Head and Neck Cancer Treated With Radiotherapy
Not Applicable
Completed
- Conditions
- Head and Neck CancerRadiation- Induced MucositisAdverse Effect of Radiation Therapy
- First Posted Date
- 2017-12-02
- Last Posted Date
- 2020-08-05
- Lead Sponsor
- Chulabhorn Hospital
- Target Recruit Count
- 120
- Registration Number
- NCT03359187
- Locations
- 🇹🇭
Chulabhorn Hospital, Bangkok, Thailand
Needs-Based Patient Education Versus Traditional Patient Education in Reducing Pre-operative Anxiety in Day Surgery
Not Applicable
Completed
- Conditions
- SurgeryEducational Problems
- First Posted Date
- 2016-12-26
- Last Posted Date
- 2017-01-10
- Lead Sponsor
- Chulabhorn Hospital
- Target Recruit Count
- 470
- Registration Number
- NCT03003091
Effectiveness of Knowledge by Video and Handbook of Liver Cancer Patients With First Trans-arterial Chemoembolization
Not Applicable
- Conditions
- Cancer
- First Posted Date
- 2016-05-11
- Last Posted Date
- 2016-05-11
- Lead Sponsor
- Chulabhorn Hospital
- Target Recruit Count
- 80
- Registration Number
- NCT02768428
- Locations
- 🇹🇭
Chulabhorn Hospital, Thailand, Bangkok, Thailand
News
Thailand Achieves Pharmaceutical Independence with First Domestically Produced Targeted Cancer Drugs
Thailand has developed its first domestically produced targeted cancer drugs, IMCRANIB 100 and HERDARA, without foreign technology transfer, marking a historic milestone in pharmaceutical independence.